Fibromyalgia, infection and vaccination: Two more parts in the etiological puzzle

Journal of Autoimmunity

Volumn 27, Issue 3, 2006, Pages 145-152

  Ablin, Jacob N ^a   Shoenfeld, Yehuda ^b   Buskila, Dan ^c  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Fibromyalgia; Infection; Vaccination

Indexed keywords

AMITRIPTYLINE; ANTHRAX VACCINE; ANTIBIOTIC AGENT; CEFTRIAXONE; CHOLERA VACCINE; DOXYCYCLINE; LYME DISEASE VACCINE; PERTUSSIS VACCINE; PLAGUE VACCINE; RUBELLA VACCINE; TETANUS TOXOID; TYPHOID VACCINE; VACCINE;

ANTHRAX; ARTHRALGIA; ARTHRITIS; CHOLERA; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; FIBROMYALGIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYME DISEASE; MYALGIA; MYCOPLASMA; NAUSEA; PAIN; PATHOGENESIS; PERSIAN GULF SYNDROME; PHOTOSENSITIVITY; PLAGUE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; STRESS; TETANUS; TYPHOID FEVER; VACCINATION; VACCINATION REACTION;

FIBROMYALGIA; HUMANS; INFECTION; PERSIAN GULF SYNDROME; VACCINATION;

EID: 33846086560     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2006.09.004     Document Type: Review

References (82)

1. Crofford L.J., and Clauw D. Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed?. Arthritis Rheum 46 5 (2002) 1136-1138
2. Wolfe F., Smythe H., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 2 (1990) 160-172
3. Lautenbacher S., and Rollman G. Possible deficiencies of pain modulation in fibromyalgia. Clin J Pain 13 3 (1997) 189-196
4. Staud R., Cannon R., Mauderli A.P., Robinson M.E., Price D.D., and Vierck Jr. C.J. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 102 1-2 (2003) 87-95
5. Gracely R.H., Petzke F., Wolf J.M., and Clauw D.J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46 5 (2002) 1333-1343
6. Cohen A.D., and Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 9 6 (1996) 699-703
7. Molina V., and Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38 3 (2005) 235-245
8. Dadabhoy D., and Clauw D. Therapy insight: fibromyalgia - a different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2 7 (2006) 364-372
9. Miller R.G., Carson P., Moussavi R.S., Green A.T., Baker A.J., and Weiner M.W. Fatigue and myalgia in AIDS patients. Neurology 41 10 (1991) 1603-1607
10. Buchwald D., Goldenberg D., Sullivan J.L., and Komaroff A.L. The "chronic, active Epstein-Barr virus infection" syndrome and primary fibromyalgia. Arthritis Rheum 30 10 (1987) 1132-1136
11. Whelton C.L., Salit I., and Moldofsky H. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol 19 6 (1992) 939-943
12. Moldofsky H. Nonrestorative sleep and symptoms after a febrile illness in patients with fibrositis and chronic fatigue syndromes. J Rheumatol Suppl 19 (1989) 150-153
13. Glaser R., Padgett D., Litsky M.L., Baiocchi R.A., Yang E.V., Chen M., et al. Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19 2 (2005) 91-103
14. Nash P., Chard M., and Hazleman B. Chronic coxsackie B infection mimicking primary fibromyalgia. J Rheumatol 16 11 (1989) 1506-1508
15. Leventhal L.J., Naides S., and Freundlich B. Fibromyalgia and parvovirus infection. Arthritis Rheum 34 10 (1991) 1319-1324
16. Berg A.M., Naides S., and Simms R.W. Established fibromyalgia syndrome and parvovirus B19 infection. J Rheumatol 20 11 (1993) 1941-1943
17. Steere A.C., Malawista S., Snydman D.R., Shope R.E., Andiman W.A., Ross M.R., et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20 1 (1977) 7-17
18. Schned ES, Williams D. Special concerns in Lyme disease. 1992. Seropositivity with vague symptoms and development of fibrositis. Postgrad Med 91(7):65-8.
19. Sigal L. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med 88 6 (1990) 57-81
20. Dinerman H., and Steere A. Lyme disease associated with fibromyalgia. Ann Intern Med 117 4 (1992) 281-285
21. Lightfoot Jr. R.W., Luft B., Rahn D.W., Steere A.C., Sigal L.H., Zoschke D.C., et al. Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive serologic result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med 119 6 (1993) 503-509
22. Hsu V.M., Patella S., and Sigal L.H. Chronic Lyme disease" as the incorrect diagnosis in patients with fibromyalgia. Arthritis Rheum 36 11 (1993) 1493-1500
23. Cairns V., and Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 34 6 (2005) 1340-1345
24. Komaroff A.L., Bell D., Cheney P.R., and Lo S.C. Absence of antibody to Mycoplasma fermentans in patients with chronic fatigue syndrome. Clin Infect Dis 17 6 (1993) 1074-1075
25. Nasralla M., Haier J., and Nicolson G.L. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 18 12 (1999) 859-865
26. Endresen G. Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes. Rheumatol Int 23 5 (2003) 211-215
27. Nicolson G.L., Gan R., and Haier J. Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS 111 5 (2003) 557-566
28. Vernon S.D., Shukla S., and Reeves W.C. Absence of Mycoplasma species DNA in chronic fatigue syndrome. J Med Microbiol 52 11 (2003) 1027-1028
29. Donta S.T., Engel C.J., Collins J.F., Baseman J.B., Dever L.L., Taylor T., et al. Benefits and harms of doxycycline treatment for Gulf War veterans' illnesses: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 141 2 (2004) 85-94
30. Buskila D., Shnaider A., Neumann L., Zilberman D., Hilzenrat N., and Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 157 21 (1997) 2497-2500
31. Rivera J., de Diego A., Trinchet M., and Garcia Monforte A. Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol 36 9 (1997) 981-985
32. Lovy M.R., Starkebaum G., and Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 23 6 (1997) 979-983
33. Buskila D., Shnaider A., Neumann L., Lorber M., Zilberman D., Hilzenrat N., et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 28 2 (1998) 107-113
34. Narvaez J., Nolla J., and Valverde-Garcia J. Lack of association of fibromyalgia with hepatitis C virus infection. J Rheumatol 32 6 (2005) 1118-1121
35. Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Silver D., and Weisman M.H. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology (Oxford) 40 7 (2001) 743-749
36. Uceyler N., Valenza R., Stock M., Schedel R., Sprotte G., and Sommer C. Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54 8 (2006) 2656-2664
37. Mullington J.M., Hinze-Selch D., and Pollmacher T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci 933 (2001) 201-210
38. Gur A., Karakoc M., Nas K., Cevik R., Denli A., and Sarac J. Cytokines and depression in cases with fibromyalgia. J Rheumatol 29 2 (2002) 358-361
39. Thompson M.E., and Barkhuize A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep 7 5 (2003) 342-347
40. Adak B., Tekeoglu I., Ediz L., Budancamanak M., Yazgan T., Karahocagil K., et al. Fibromyalgia frequency in hepatitis B carriers. J Clin Rheumatol 11 3 (2005) 157-159
41. Berman A., Espinoza L., Diaz J.D., Aguilar J.L., Rolando T., Vasey F.B., et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 85 1 (1988) 59-64
42. Buskila D., Gladman D., Langevitz P., Bookman A.A., Fanning M., and Salit I.E. Rheumatologic manifestations of infection with the human immunodeficiency virus (HIV). Clin Exp Rheumatol 8 6 (1990) 567-573
43. Winchester R., Bernstein D., Fischer H.D., Enlow R., and Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 106 1 (1987) 19-26
44. Buskila D., Gladman D., Langevitz P., Urowitz S., and Smythe H.A. Fibromyalgia in human immunodeficiency virus infection. J Rheumatol 17 9 (1990) 1202-1206
45. Simms R.W., Zerbini C., Ferrante N., Anthony J., Felson D.T., and Craven D.E. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. The Boston City Hospital Clinical AIDS Team. Am J Med 92 4 (1992) 368-374
46. Marquez J., Restrepo C., Candia L., Berman A., and Espinoza L.R. Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J Rheumatol 31 4 (2004) 741-746
47. Kumar M., Kumar A., Morgan R., Szapocznik J., and Eisdorfer C. Abnormal pituitary-adrenocortical response in early HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 6 1 (1993) 61-65
48. Biglino A., Limon P., Forno B., Pollono A., Cariti G., Molinatti G.M., et al. Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. Eur J Endocrinol 133 2 (1995) 173-179
49. Verges B., Chavanet P., Desgres J., Vaillant G., Waldner A., Brun J.M., et al. Adrenal function in HIV infected patients. Acta Endocrinol (Copenh) 121 5 (1989) 633-637
50. Crofford L.J., Pillemer S., Kalogeras K.T., Cash J.M., Michelson D., Kling M.A., et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37 11 (1994) 1583-1592
51. Adler G.K., Kinsley B., Hurwitz S., Mossey C.J., and Goldenberg D.L. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106 5 (1990) 534-543
52. McLean S.A., Williams D., Harris R.E., Kop W.J., Groner K.H., Ambrose K., et al. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 52 11 (2005) 3660-3669
53. Rubinstein M.L., and Selwyn P. High prevalence of insomnia in an outpatient population with HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 19 3 (1998) 260-265
54. Vosvick M., Gore-Felton C., Ashton E., Koopman C., Fluery T., Israelski D., et al. Sleep disturbances among HIV-positive adults: the role of pain, stress, and social support. J Psychosom Res 57 5 (2004) 459-463
55. Clifford D.B., Evans S., Yang Y., Acosta E.P., Goodkin K., Tashima K., et al. Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individuals. Ann Intern Med 143 10 (2005) 714-721
56. Koppel B.S., and Bharel C. Use of amitriptyline to offset sleep disturbances caused by efavirenz. AIDS Patient Care STDS 19 7 (2005) 419-420
57. Smith M.T., Huang M., and Manber R. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev 25 5 (2005) 559-592
58. Moldofsky H. Management of sleep disorders in fibromyalgia. Rheum Dis Clin North Am 28 2 (2002) 353-365
59. Penzak S.R., Reddy Y., and Grimsley S.R. Depression in patients with HIV infection. Am J Health Syst Pharm 57 4 (2000) 376-386
60. Ciesla J.A., and Roberts J. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry 158 5 (2001) 725-730
61. Fishbain D.A., Cutler R., Rosomoff H.L., and Rosomoff R.S. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 13 2 (1997) 116-137
62. Giesecke T., Gracely R., Williams D.A., Geisser M.E., Petzke F.W., and Clauw D.J. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 52 5 (2005) 1577-1584
63. Allen A. Is RA27/3 rubella immunization a cause of chronic fatigue?. Med Hypotheses 27 3 (1988) 217-220
64. Weibel R.E., and Benor D. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the National Vaccine Injury Compensation Program. Arthritis Rheum 39 9 (1996) 1529-1534
65. Tingle A.J., Mitchell L., Grace M., Middleton P., Mathias R., MacWilliam L., et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 349 9061 (1997) 1277-1281
66. Mitchell L.A., Tingle A., Grace M., Middleton P., and Chalmers A.C. Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations. J Rheumatol 27 2 (2000) 418-423
67. Lathrop S.L., Ball R., Haber P., Mootrey G.T., Braun M.M., Shadomy S.V., et al. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine 20 11-12 (2002) 1603-1608
68. Lange G., Tiersky L., Scharer J.B., Policastro T., Fiedler N., Morgan T.E., et al. Cognitive functioning in Gulf War Illness. J Clin Exp Neuropsychol 23 2 (2001) 240-249
69. Fukuda K., Nisenbaum R., Stewart G., Thompson W.W., Robin L., Washko R.M., et al. Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 280 11 (1998) 981-988
70. Ford J.D., Campbell K., Storzbach D., Binder L.M., Anger W.K., and Rohlman D.S. Posttraumatic stress symptomatology is associated with unexplained illness attributed to Persian Gulf War military service. Psychosom Med 63 5 (2001) 842-849
71. Binder L.M., and Campbell K. Medically unexplained symptoms and neuropsychological assessment. J Clin Exp Neuropsychol 26 3 (2004) 369-392
72. Unwin C., Blatchle N., Coker W., Ferry S., Hotopf M., Hull L., et al. Health of UK servicemen who served in Persian Gulf War. Lancet 353 9148 (1999) 169-178
73. Hotopf M., David A., Hull L., Ismail K., Unwin C., and Wessely S. Role of vaccinations as risk factors for ill health in veterans of the Gulf War: cross sectional study. BMJ 320 7246 (2000) 1363-1367
74. Hotopf M., David A., Hull L., Nikalaou V., Unwin C., and Wessely S. Risk factors for continued illness among Gulf War veterans: a cohort study. Psychol Med 34 4 (2004) 747-754
75. Raphael K.G., Janal M.N., and Nayak S. Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. Pain Med 5 1 (2004) 33-41
76. Rook G.A., and Zumla A. Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?. Lancet 349 9068 (1997) 1831-1833
77. Straus S. Chronic fatigue syndrome. In: Rosen S. (Ed). Medicine for the public (1996), National Institutes of Health, Bethesda, MD 1-5 [Publication no. 90-3059]
78. Mu H.H., and Sewell W. Enhancement of interleukin-4 production by pertussis toxin. Infect Immun 61 7 (1993) 2834-2840
79. Ramirez F., Fowell D., Puklavec M., Simmonds S., and Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 156 7 (1996) 2406-2412
80. Bernton E., Hoover D., Galloway R., and Popp K. Adaptation to chronic stress in military trainees. Adrenal androgens, testosterone, glucocorticoids, IGF-1, and immune function. Ann N Y Acad Sci 774 (1995) 217-231
81. Skowera A., Cleare A., Blair D., Bevis L., Wessely S.C., and Peakman M. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 135 2 (2004) 294-302
82. Brimacombe M., Zhang Q., Lange G., and Natelson B.H. Immunological variables mediate cognitive dysfunction in Gulf War veterans but not civilians with chronic fatigue syndrome. Neuroimmunomodulation 10 2 (2002-2003) 93-100